Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus (Q36693199)
scientific article published on 26 December 2006
Language:
(P31) (Q13442814)
(P304) 51-60
(P407) (Q1860)
(P433) 1
(P478) 41
(P577) Tuesday, December 26, 2006
(P921) (Q3025883)
(P1433) (Q4767858)
(P1476) "Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus" (language: en)
(P2093) R Keith Campbell
(P2860) (Q33864120)
(Q36012529)
(Q28117412)
(Q35545683)
(Q34312081)
(Q36012476)
(Q51665235)
(Q34758871)
(Q35844598)
(Q44273278)
(Q38361101)
(Q44333542)
(Q33220335)
(Q39227026)
(Q36012520)
(Q28582758)
(Q28510783)
(Q35669308)
(Q43623564)
(Q35824086)
(Q43778779)
(Q45306841)
(Q51606971)
(Q34061916)
(Q43935399)
(Q44193794)
(Q40663660)
(Q36012488)
(Q40710884)
(Q28578709)
(Q47234077)
(Q38363214)
(Q51601217)
(Q43919658)
(Q40920945)
(Q24609542)
(Q36012462)
(Q46946154)
(Q42525265)
(Q51566651)
(Q43973972)
(Q32039449)
(Q54153850)
(Q43972544)
(Q30320781)
(Q35961973)
(Q43972608)
(Q28260260)
(Q51495176)
(Q33209301)
(Q38324621)
(Q46458868)
(Q46458866)
(Q45124469)
(Q44136587)
(Q44474559)
(Q58449089)
(Q58448934)
(P13046) (Q7318358)
other details
description scientific article published on 26 December 2006

External Links